These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8401406)

  • 1. Erythrocyte uptake and protein binding of cyclosporin A (CyA) in human blood: factors affecting CyA concentration in erythrocytes.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Jul; 16(7):702-7. PubMed ID: 8401406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method for predicting the cyclosporin A erythrocyte-to-plasma distribution ratio in blood, and its clinical assessment.
    Shibata N; Yamaji A; Park K; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y; Hodohara K; Hosoda S
    Biol Pharm Bull; 1994 May; 17(5):709-14. PubMed ID: 7920439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.
    Shibata N; Minouchi T; Ono T; Shimakawa H
    J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between apparent total body clearance of cyclosporin A and its erythrocyte-to-plasma distribution ratio in renal transplant patients.
    Shibata N; Minouchi T; Yamaji A; Park KI; Inoue H; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y
    Biol Pharm Bull; 1995 Jan; 18(1):115-21. PubMed ID: 7735224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo distribution and erythrocyte binding characteristics of cyclosporin in renal transplant patients.
    Kurokawa N; Kadobayashi M; Yamamoto K; Arakawa Y; Sawada M; Takahara S; Okuyama A; Yanaihara C
    J Pharm Pharmacol; 1996 Jun; 48(6):553-9. PubMed ID: 8832486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.
    Legg B; Rowland M
    Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
    Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
    J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cyclosporine A uptake in human erythrocytes.
    Reichel C; von Falkenhausen M; Brockmeier D; Dengler HJ
    Eur J Clin Pharmacol; 1994; 46(5):417-9. PubMed ID: 7957535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram for predicting optimal dosage of cyclosporine in renal transplant patients: taking physiological factors into consideration for regimen during immunosuppressive therapy.
    Shibata N; Hoshino N; Minouchi T; Yamaji A
    Biol Pharm Bull; 1995 Oct; 18(10):1423-9. PubMed ID: 8593449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution characteristics of immunosuppressants FK506 and cyclosporin A in the blood compartment.
    Takada K; Katayama N; Kiriyama A; Usuda H
    Biopharm Drug Dispos; 1993 Nov; 14(8):659-71. PubMed ID: 7508273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural repeats in cyclosporin A.
    Denesyuk AI; Lundell J; Goldman A; Zav'yalov VP; Korpela T
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1438-42. PubMed ID: 8280162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-dependent cortisol distribution among the blood compartments in man.
    Lentjes EG; Romijn FH
    J Clin Endocrinol Metab; 1999 Feb; 84(2):682-7. PubMed ID: 10022438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in cellular ion transport and arterial pressure in renal transplant recipients undergoing cyclosporin treatment].
    Borca M; Guarena C; Boero R; Basolo B; Maffei S; Forneris G; Iadarola GM; Stramignoni E; Quarello F
    Minerva Urol Nefrol; 1992; 44(2):139-42. PubMed ID: 1329239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the effect of secreted cyclophilin B on immunosuppressive activity of cyclosporine.
    Denys A; Allain F; Masy E; Dessaint JP; Spik G
    Transplantation; 1998 Apr; 65(8):1076-84. PubMed ID: 9583869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high-performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1877-80. PubMed ID: 2805168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-dependent binding of cyclosporine to an erythrocyte protein.
    Agarwal RP; Threatte GA; McPherson RA
    Clin Chem; 1987 Apr; 33(4):481-5. PubMed ID: 3549056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A has no impact on alterations of the lipid profile after renal transplantation.
    Rosman J; Evequoz D; Landmann J; Thiel G
    Transpl Int; 1992; 5 Suppl 1():S532-5. PubMed ID: 14621868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.